VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DSS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DSSDSS, Inc.
$0.58$5M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksDSSFinancials

DSS, Inc. (DSS) Financials

29Y historyFree accessUpdated daily

Revenue growth has decelerated to a 12.6% year-over-year decline in 2026Q1, compounded by a structural deficit that resulted in a -126.7% operating margin.

DSS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97
Sales/Revenue20.14M20.76M19.1M25.93M28.38M20.27M15.37M15.55M18.52M18.66M19.18M17.51M18.29M17.45M17.12M13.38M13.38M9.91M6.64M5.99M4.31M1.27M1.59M1.28M679.52K000025.95K
Revenue Growth %-0.22%8.69%-26.36%-8.63%39.99%31.95%-1.18%-16.01%-0.79%-2.69%9.55%-4.28%4.78%1.97%27.88%0.02%35.01%49.2%10.88%39.06%240.21%-20.59%24.13%89.07%-----100%-
Cost of Goods Sold23.27M22.93M23.54M25.39M32.99M16.82M11.01M10.34M11.85M11.01M11.12M10.67M11.69M10.46M10.98M9.21M9.7M6.26M3.03M2.86M2.32M643.18K936.68K597.16K230.84K00030K428.48K
COGS % of Revenue-110.45%123.26%97.91%116.24%82.98%71.65%66.51%64.02%58.99%57.98%60.93%63.92%59.92%64.14%68.83%72.46%63.12%45.6%47.8%53.89%50.79%58.73%46.48%33.97%----1651.44%
Gross Profit-3.14M-2.17M-4.44M543K-4.61M3.45M4.36M5.21M6.66M7.65M8.06M6.84M6.6M6.99M6.14M4.17M3.69M3.66M3.61M3.13M1.99M623.21K658.08K687.58K448.68K0-1.06M0-30K-402.54K
Gross Margin %-15.58%-10.45%-23.26%2.09%-16.24%17.02%28.35%33.49%35.98%41.01%42.02%39.07%36.08%40.08%35.86%31.17%27.54%36.88%54.4%52.2%46.11%49.21%41.27%53.52%66.03%-----1551.44%
Gross Profit Growth %-51.17%-918.05%111.78%-233.56%-20.79%-16.34%-21.82%-12.95%-5.02%17.8%3.67%-5.67%13.96%47.12%13.2%0.82%1.15%15.56%57.42%218.77%-5.3%-4.29%53.25%-100%-100%92.55%-
Operating Expenses13.06M12.27M16.49M24.14M25.37M26.98M15.79M7.83M8.37M7.88M8.72M20.92M53.08M15.15M9.91M7.65M7.58M7.37M10.63M10.15M6.75M3.31M2.38M2.12M548.07K170.36K1.09M34.87K39.34K52.03K
OpEx % of Revenue-59.09%86.34%93.07%89.38%133.07%102.73%50.32%45.21%42.22%45.46%119.53%290.23%86.8%57.91%57.13%56.66%74.33%160.07%169.39%156.75%261.18%149.35%164.77%80.66%----200.52%
Selling, General & Admin10.98M10.18M10.37M11.98M20.07M22.4M13.47M6.89M6.84M6.47M7.33M9.27M10.77M11.67M9.07M7.08M6.14M5.73M7.43M7.97M5.38M2.46M1.86M1.78M239.85K170.36K34.73K34.87K39.34K54.03K
SG&A % of Revenue-49.06%54.3%46.19%70.7%110.5%87.64%44.33%36.94%34.64%38.2%52.96%58.88%66.84%52.97%52.87%45.86%57.85%111.87%133.1%124.76%193.92%116.7%138.55%35.3%----208.22%
Research & Development0340K278K1.69M1.26M1.08M210K-12K146K000462K254K491.4K285.45K265.36K291.54K432.55K420.06K352.8K313.66K421.72K231.72K42.23K00000
R&D % of Revenue-1.64%1.46%6.5%4.43%5.33%1.37%-0.08%0.79%---2.53%1.46%2.87%2.13%1.98%2.94%6.51%7.01%8.19%24.77%26.44%18.04%6.21%-----
Other Operating Expenses1000K1.74M5.84M10.47M4.05M3.5M2.11M943K1.39M1.41M1.39M11.65M41.85M3.23M353.74K284.72K1.18M1.34M2.77M1.75M1.03M538.11K99.01K105.14K265.99K01.06M00-2K
Operating Income-16.2M-14.43M-20.93M-23.59M-29.98M-23.53M-11.43M-2.62M-1.71M-225.86K-660.06K-14.08M-46.48M-8.15M-3.77M-3.47M-3.9M-3.71M-7.02M-7.02M-4.77M-2.68M-1.72M-1.43M-99.39K-170K-1.09M-34.87K-69.34K-454.56K
Operating Margin %-80.44%-69.54%-109.6%-90.98%-105.62%-116.04%-74.37%-16.83%-9.23%-1.21%-3.44%-80.45%-254.16%-46.72%-22.05%-25.96%-29.12%-37.45%-105.67%-117.19%-110.64%-211.97%-108.09%-111.25%-14.63%-----1751.95%
Operating Income Growth %-31.04%11.29%21.3%-27.41%-105.88%-336.68%-53.16%-656.5%65.78%95.31%69.7%-469.98%-116.07%-8.63%10.83%-4.95%47.11%0.02%-47.28%-77.59%-55.73%-20.6%-1338.11%41.54%84.45%-3035.62%49.71%84.75%-
EBITDA-14.06M-10.9M-17.95M-18.39M-17.8M-19.21M-10.36M-1.47M-427.03K1.19M731.76K-12.52M-41.2M-5.19M-2.93M-2.71M-2.64M-2.05M-4.73M-5.08M-3.53M-1.96M-1.6M-1.32M-71.19K-148.44K-34.73K-34.87K-69.34K-454.56K
EBITDA Margin %-69.81%-52.53%-93.97%-70.91%-62.73%-94.73%-67.42%-9.43%-2.31%6.37%3.82%-71.55%-225.32%-29.73%-17.11%-20.23%-19.69%-20.69%-71.22%-84.72%-82.03%-155.07%-100.07%-103.07%-10.48%-----1751.95%
EBITDA Growth %19.45%39.24%2.4%-3.27%7.29%-85.39%-606.68%-243.3%-135.95%62.35%105.84%69.6%-694.22%-77.14%-8.19%-2.74%-28.49%56.66%6.79%-43.63%-79.97%-23.05%-20.52%-1759.99%52.04%-327.42%0.4%49.71%84.75%-
D&A (Non-Cash Add-back)3.01M3.53M2.98M5.21M12.17M4.32M1.07M1.15M1.28M1.41M1.39M1.56M5.27M2.97M845.14K766.98K1.26M1.66M2.29M1.95M1.23M720.6K127.89K105.14K28.2K21.57K1.06M000
EBIT-28.29M-27.22M-53.41M-73.49M-42.61M-40.01M469K-2.6M1.63M-375.8K-691.21K-13.95M-46.53M-8.11M-4.03M-3.11M-4.29M-3.71M-8.13M-7.02M-4.77M-2.68M-1.72M-1.43M-99.39K-170K-34.73K-34.87K0-454.56K
Net Interest Income-222K-215K57K736K503K4.36M-122K-103K-182.44K-373.25K-279K-335K-317K-246K-228K-259K-290K-241K-136K93.4K59.98K85.6K55.18K0000000
Interest Income50K51K340K1.29M629K4.56M69K25K8.63K4.21K000000018.14K65893.4K59.98K85.6K55.18K0000000
Interest Expense272K266K283K553K126K196K191K128K191.07K377.46K279K335K317K246K228K259.14K290.09K258.92K136.31K00000000000
Other Income/Expense-12.33M-13.05M-32.77M-50.45M-12.76M-16.67M11.71M-103K3.19M-373.25K-279.21K-204K-366.8K-200.92K-487.95K101.78K-688.8K-258.8K-1.25M64.77K41.51K81.27K26.75K-22.92K-8.96K-59.21K0000
Pretax Income-28.52M-27.49M-53.7M-74.04M-42.74M-40.2M286K-2.72M1.48M-599.12K-939.27K-14.29M-46.85M-8.36M-4.26M-3.37M-4.58M-3.97M-8.27M-6.96M-4.73M-2.6M-1.7M-1.45M-108.35K-230K-1.09M-34.87K-69.34K-454.56K
Pretax Margin %-141.66%-132.43%-281.19%-285.5%-150.57%-198.28%1.86%-17.49%8%-3.21%-4.9%-81.62%-256.16%-47.87%-24.9%-25.2%-34.26%-40.06%-124.43%-116.11%-109.68%-205.55%-106.41%-113.03%-15.94%-----1751.95%
Income Tax-468K08K4K172K-4.03M-1.77M-125K16.59K-20.96K10.73K22.18K-988.63K-10.95M18.95K-150.18K-1.12M18.95K18.96K19K006.89K008.68K5002K2K2K
Effective Tax Rate %1.64%0%-0.01%-0.01%-0.4%10.03%-620.28%4.6%1.12%3.5%-1.14%-0.16%2.11%131.04%-0.44%4.45%24.47%-0.48%-0.23%-0.27%0%0%-0.41%0%0%-3.78%-0.05%-5.74%-2.88%-0.44%
Net Income-25.02M-23.93M-46.9M-60.63M-59.84M-33.12M1.9M-2.89M1.46M-578.16K-950K-14.31M-41.16M2.59M-4.28M-3.22M-3.46M-3.99M-8.29M-6.99M-4.83M-2.84M-1.7M-1.45M-108.35K-238K-1.09M-36.87K-71.34K-456.56K
Net Margin %-124.24%-115.28%-245.57%-233.78%-210.83%-163.35%12.36%-18.58%7.91%-3.1%-4.95%-81.74%-225.06%14.86%-25.01%-24.08%-25.88%-40.26%-124.72%-116.62%-112.16%-224.48%-106.84%-113.03%-15.94%-----1759.66%
Net Income Growth %47.45%48.97%22.65%-1.32%-80.68%-1844.02%165.73%-297.21%353.39%39.14%93.36%65.23%-1686.91%160.58%-32.86%6.95%13.21%51.84%-18.58%-44.58%-69.99%-66.84%-17.33%-1240.31%54.48%78.24%-2866.8%48.32%84.38%-
Net Income (Continuing)-28.06M-27.49M-53.71M-74.04M-42.91M-36.17M2.06M-2.6M1.46M-578.16K-950K-14.31M-45.86M2.59M-4.28M-3.22M-3.46M-3.99M-8.29M-6.98M-4.73M-2.6M-1.7M-1.45M-108.35K-238K-1.09M-36.87K-71.34K-456.56K
Discontinued Operations000-3.48M-26.75M2.13M-641K-294K00000000000-11.56K-106.82K-239.72K00000000
Minority Interest9.17M9.55M12.48M19.29M31.12M36.41M3.43M0000004.5M0000000000000000
EPS (Diluted)-2.59-2.66-6.63-8.67-10.73-13.608.40-68.002.60-24.00-42.00-720.01-117.30192.00-24.66-19.88-31.12-32.57-71.01-61.51-888.01-28.40-384.00-384.00-48.00-27.72-135.51-0.15-0.30-0.06
EPS Growth %59%59.88%23.53%19.2%21.1%-261.9%112.35%-2715.38%110.83%42.86%94.17%-513.82%-161.09%878.59%-24.04%36.12%4.45%54.13%-15.44%93.07%-3026.8%92.6%0%-700%-73.16%79.54%-90240%50%-421.74%-
EPS (Basic)--2.66-6.63-8.67-10.73-13.2214.40-61169.592.63-24.00-42.00-720.01-2352.02192.00-25.20-19.88-31.12-32.57-71.01-61.51-888.01-576.01-384.00-384.00-1.41-27.72-135.51-0.15-0.30-0.06
Diluted Shares Outstanding9.65M8.99M7.07M7M5.58M2.58M300.96K47564.35K480.81K435.61K397.99K350.88K265.32K173.57K162.12K147.96K122.5K116.68K113.58K107.43K100.09K90.8K77.84K76.96K8.6K8.07K240K240K7.95M
Basic Shares Outstanding9.65M8.99M7.07M7M5.58M2.58M177.42K42.51K557.47K480.81K435.61K397.99K350.88K265.32K169.87K162.12K147.96K122.5K116.68K113.58K107.43K100.09K90.8K77.84K76.96K8.6K8.07K240K240K7.95M
Dividend Payout Ratio------------------------------

Key Metrics

Growth RegimeDecelerating
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Structural negative gross margins

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Fragmented Revenue Lacks Organic Momentum

As reported in recent financial filings, DSS experienced a 12.6% year-over-year revenue decline in 2026Q1, highlighting the volatility inherent in its diversified holding company model where disparate segments struggle to generate consistent, scalable top-line growth across its various fintech, biotech, and packaging business units.

The revenue trajectory appears highly erratic, suggesting that the company's transition into a conglomerate has not yet yielded a cohesive growth engine. Investors should monitor whether the reliance on project-based biotech and cyclical lending segments will continue to produce such inconsistent quarterly results.

Structural Deficit in Gross Profitability

Based on the company's reported figures, the gross margin plummeted to -27.8% in 2026Q1, indicating that the direct costs of production and service delivery consistently exceed the revenue generated by its fragmented portfolio of industrial and speculative business operations.

This persistent negative gross margin suggests a fundamental inability to achieve economies of scale or pricing power within its core packaging and marketing segments. Such a cost structure implies that the business model may be fundamentally broken at the unit-economic level, requiring significant rationalization.

Operating Leverage Obscured by Losses

According to historical income statements, the company's operating margin of -126.7% in 2026Q1 demonstrates that administrative and overhead expenses are significantly outstripping gross profit, leaving no room for operational leverage as the firm attempts to manage a complex, multi-industry corporate infrastructure.

The lack of operating leverage appears to be a direct consequence of maintaining a high fixed-cost base across unrelated sectors. Without a substantial increase in revenue scale, the current SG&A burden will likely continue to exacerbate net losses, regardless of any potential improvements in individual subsidiary performance.

Sustainability of Capital-Intensive Incubator Model

As evidenced by the consistent net losses and negative margins, the company's incubator strategy faces severe scrutiny, as the administrative costs of managing diverse, loss-making subsidiaries appear to permanently outweigh the potential long-term value of its minority equity stakes in various biotech and fintech startups.

Short-sellers would likely focus on the company's inability to generate positive cash flow from its core operations, which necessitates constant reliance on external capital. The complexity of the consolidated financial statements may mask the true extent of the cash burn occurring within its speculative business units.

DSS — Frequently Asked Questions

Quick answers to the most common questions about buying DSS stock.

What was DSS, Inc.'s (DSS) revenue in 2025?

For fiscal year 2025, DSS, Inc. (DSS) reported total revenue of $20.8M. This represents a 79900.8% increase compared to $0.0M in 1997.

Is DSS, Inc. (DSS) profitable?

DSS, Inc. (DSS) reported a net loss of $23.9M for the fiscal year ending 2025.

What is DSS, Inc.'s operating profit margin?

DSS, Inc. (DSS) reported an operating income of $-14.4M, resulting in an operating profit margin of -69.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is DSS, Inc.'s gross profit and gross margin?

DSS, Inc. (DSS) generated $-2.2M in gross profit for the year, representing a gross profit margin of -10.4%. This demonstrates the company's core pricing power and production efficiency.